Viewing Study NCT02575833


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2026-03-08 @ 11:22 PM
Study NCT ID: NCT02575833
Status: COMPLETED
Last Update Posted: 2018-08-24
First Post: 2015-10-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Treadmill Cardiovascular Safety Study of Erenumab (AMG 334)
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stable Angina View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Angina View
None Stable Angina View
None Cardiovascular Disease View
None Exercise-induced Angina View